DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,694 | +17.2% | 10,687 | +23.4% | 0.04% | +12.5% |
| Q4 2022 | $2,298 | -99.9% | 8,658 | +40.6% | 0.04% | +42.9% |
| Q3 2022 | $1,591,000 | -94.2% | 6,158 | -92.6% | 0.03% | -79.6% |
| Q1 2022 | $27,495,000 | 0.0% | 83,568 | 0.0% | 0.14% | 0.0% |
| Q4 2021 | $27,495,000 | -8.1% | 83,568 | -15.0% | 0.14% | -11.0% |
| Q3 2021 | $29,915,000 | -38.0% | 98,261 | -45.4% | 0.15% | -24.9% |
| Q2 2021 | $48,279,000 | -13.6% | 179,904 | -27.6% | 0.20% | -15.3% |
| Q1 2021 | $55,895,000 | -14.7% | 248,334 | -15.8% | 0.24% | -20.1% |
| Q4 2020 | $65,528,000 | +2.7% | 294,984 | -0.4% | 0.30% | -9.0% |
| Q3 2020 | $63,776,000 | -17.4% | 296,179 | -32.1% | 0.33% | -25.5% |
| Q2 2020 | $77,183,000 | +71.4% | 436,481 | +34.1% | 0.45% | +37.5% |
| Q1 2020 | $45,038,000 | -5.7% | 325,399 | +4.5% | 0.32% | +20.4% |
| Q4 2019 | $47,779,000 | -4.1% | 311,302 | -9.8% | 0.27% | +13.4% |
| Q3 2019 | $49,828,000 | -8.7% | 345,000 | -9.7% | 0.24% | -13.1% |
| Q2 2019 | $54,595,000 | +5.2% | 382,000 | -2.8% | 0.27% | +3.4% |
| Q1 2019 | $51,884,000 | +11.8% | 393,000 | -12.7% | 0.26% | -1.5% |
| Q4 2018 | $46,404,000 | -5.1% | 450,000 | 0.0% | 0.27% | +4.3% |
| Q3 2018 | $48,897,000 | +10.1% | 450,000 | 0.0% | 0.26% | +6.2% |
| Q2 2018 | $44,406,000 | +0.8% | 450,000 | 0.0% | 0.24% | -2.4% |
| Q1 2018 | $44,060,000 | +5.5% | 450,000 | 0.0% | 0.25% | +6.4% |
| Q4 2017 | $41,769,000 | +8.2% | 450,000 | 0.0% | 0.23% | +23.2% |
| Q3 2017 | $38,601,000 | +1.6% | 450,000 | 0.0% | 0.19% | -2.1% |
| Q2 2017 | $37,976,000 | -44.6% | 450,000 | -43.8% | 0.19% | -45.2% |
| Q1 2017 | $68,543,000 | +6.9% | 801,397 | -2.7% | 0.35% | +7.9% |
| Q4 2016 | $64,132,000 | -1.5% | 823,895 | -0.8% | 0.33% | +0.6% |
| Q3 2016 | $65,115,000 | +100.7% | 830,657 | +158.6% | 0.33% | +96.4% |
| Q2 2016 | $32,447,000 | +12.6% | 321,253 | +5.7% | 0.17% | +8.5% |
| Q1 2016 | $28,821,000 | +0.4% | 303,824 | -1.7% | 0.15% | +0.7% |
| Q4 2015 | $28,713,000 | +9.4% | 309,140 | +0.4% | 0.15% | +7.0% |
| Q3 2015 | $26,240,000 | +0.7% | 307,946 | +1.1% | 0.14% | +5.2% |
| Q2 2015 | $26,065,000 | +6.9% | 304,531 | +6.1% | 0.14% | +16.4% |
| Q1 2015 | $24,378,000 | -12.7% | 287,139 | -11.8% | 0.12% | -7.2% |
| Q4 2014 | $27,909,000 | +12.8% | 325,616 | 0.0% | 0.12% | +6.8% |
| Q3 2014 | $24,740,000 | +1.4% | 325,616 | +5.1% | 0.12% | -0.8% |
| Q2 2014 | $24,388,000 | +10.3% | 309,767 | +5.1% | 0.12% | +2.6% |
| Q1 2014 | $22,107,000 | -52.9% | 294,756 | -51.6% | 0.12% | -55.4% |
| Q4 2013 | $46,972,000 | +11.4% | 608,451 | 0.0% | 0.26% | +5.3% |
| Q3 2013 | $42,178,000 | – | 608,451 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |